SCHEMBL19987767

SCHEMBL19987767

CC(Cc1nc2ccccc2s1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 4/20 0.61
▸ SMN1; SMN2 Q16637 4/20 0.58
▸ ALOX15 P16050 1/20 0.58
▸ HTT P42858 1/20 0.58
▸ CYP1A2 P05177 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ KMT2A Q03164 4/20 0.54
▸ RAB9A P51151 2/20 0.54
▸ GAA P10253 2/20 0.51
▸ MEN1 O00255 3/20 0.50
▸ MAPT P10636 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ UBE2T Q9NPD8 1/20 0.50
▸ ASIC3 Q9UHC3 1/20 0.50
▸ POLB P06746 2/20 0.49
▸ RECQL P46063 1/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ SLC13A5 Q86YT5 1/20 0.48
▸ LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9036466 0.87 HPGD (0.56) HPGDSMN1; SMN2ALOX15HTTCYP1A2
SCHEMBL5256097 0.85 SMN1; SMN2 (0.59) HPGDSMN1; SMN2ALOX15HTTCYP1A2
SCHEMBL11382409 0.82 SMN1; SMN2 (0.58) HPGDSMN1; SMN2ALOX15HTTCYP1A2
SCHEMBL29380724 0.82 SMN1; SMN2 (0.55) HPGDSMN1; SMN2ALOX15HTTCYP1A2
SCHEMBL29278085 0.82 CYP1A2 (0.51) HPGDSMN1; SMN2ALOX15HTTCYP1A2
Benzene SCHEMBL28251054 0.82 SMN1; SMN2 (0.55) HPGDSMN1; SMN2ALOX15HTTCYP1A2
SCHEMBL476053 0.82 SMN1; SMN2 (0.55) HPGDSMN1; SMN2ALOX15HTTCYP1A2
SCHEMBL11105656 0.82 SMN1; SMN2 (0.55) HPGDSMN1; SMN2ALOX15HTTCYP1A2
SCHEMBL476051 0.82 SMN1; SMN2 (0.55) HPGDSMN1; SMN2ALOX15HTTCYP1A2
SCHEMBL11382407 0.81 HPGD (0.54) HPGDSMN1; SMN2ALOX15HTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10278973-B2 Hydroxyl purine compounds and use thereof Guangdong Raynovent Biotech Co., Ltd. (CN) 2019-05-07 — — US disclosed
US-20180140607-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF Guangdong Raynovent Biotech Co., Ltd. (CN) 2018-05-24 — — US disclosed
EP-3299371-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2018-03-28 — — EP disclosed
CN-107709323-A Oxipurinol class compound and its application 广东众生药业股份有限公司 2018-02-16 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180140607-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF PNP, PDE7A, PDE2A HPGD 112/4885SMN1; SMN2 1786/4885ALOX15 1143/4885
US-10278973-B2 Hydroxyl purine compounds and use thereof PNP, PDE7A, PDE2A HPGD 112/4885SMN1; SMN2 1786/4885ALOX15 1143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback